thats not surprising, its not approved for human use in most countries. And use for asthma is at lower doses than use for fat loss. Would venture to guess that its underreported case studywise at least partly because BP issues are also at play in most AAS users- also if not aware of the link neither doctor nor patient might not reveal or query it. Though agree its understudied. Just putting the information out there so that informed choices can be made as well as risk ameliorating steps taken.